Long-acting second-generation antipsychotics, beyond efficacy: a 12-month prospective study on patients' attitudes towards treatment

被引：0
|
作者：
Pietrini, F. [1 ]
Spadafora, M. [1 ]
Talamba, G. A. [1 ]
Godini, L. [1 ]
Santangelo, A. [1 ]
Chiarello, F. [1 ]
Ballerini, A. [1 ]
机构：
[1] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Sect Neurosci, Florence, Italy
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2014年 / 24卷
关键词：
SCHIZOPHRENIA;
D O I：
10.1016/S0924-977X(14)70918-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.f.013
引用
收藏
页码：S573 / S574
页数：2
相关论文
共 50 条
  • [31] Effects of antipsychotics on bone mineral density and prolactin levels in patients with schizophrenia: a 12-month prospective study
    Wang, Mengxin
    Hou, Ruihua
    Jian, Jia
    Mi, Guolin
    Qiu, Huimin
    Cao, Bingyu
    Tang, Maoqin
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2014, 29 (02) : 183 - 189
  • [32] Continuity of care among patients newly initiated on second-generation oral or long-acting injectable antipsychotics during a schizophrenia-related inpatient stay
    Patel, Charmi
    Pilon, Dominic
    Morrison, Laura
    Holiday, Christopher
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    Benson, Carmela
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (08) : 1157 - 1166
  • [33] Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic
    Pilon, Dominic
    Joshi, Kruti
    Tandon, Neeta
    Lafeuille, Marie-Helene
    Kamstra, Rhiannon L.
    Emond, Bruno
    Lefebvre, Patrick
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 619 - 629
  • [34] Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons
    Ascher-Svanum, Haya
    Montgomery, William S.
    McDonnell, David P.
    Coleman, Kristina A.
    Feldman, Peter D.
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2012, 5 : 391 - 398
  • [35] The Effects of Use of Long-Term Second-Generation Antipsychotics on Liver and Kidney Function: A Prospective Study
    Papatriantafyllou, Evangelia
    Efthymiou, Dimitris
    Markopoulou, Maria
    Sakellariou, Efthymia-Maria
    Vassilopoulou, Emilia
    DISEASES, 2022, 10 (03)
  • [36] Efficacy and safety of second-generation long-acting injections in schizophrenia: a meta-analysis of randomized-controlled trials
    Fusar-Poli, Paolo
    Kempton, Matthew J.
    Rosenheck, Robert A.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2013, 28 (02) : 57 - 66
  • [37] Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years
    Patel, M. X.
    Haddad, P. M.
    Chaudhry, I. B.
    McLoughlin, S.
    Husain, N.
    David, A. S.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (10) : 1473 - 1482
  • [38] Persistence and adherence to second-generation antipsychotic long-acting injectable medications for schizophrenia: A comparative study in the Australian context
    Pai, Nagesh
    McGeachie, Andrew B.
    Puig, Andrea
    Huang, Tom H-W
    Brahmbhatt, Prachi
    AUSTRALASIAN PSYCHIATRY, 2023, 31 (01) : 76 - 81
  • [39] Comparative study of treatment continuation using second-generation antipsychotics in patients with schizophrenia or schizoaffective disorder
    Azekawa, Takaharu
    Ohashi, Shizuko
    Itami, Akira
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2011, 7 : 691 - 695
  • [40] A qualitative study of the attitudes of patients in an early intervention service towards antipsychotic long-acting injections
    Das, Amlan K.
    Malik, Abid
    Haddad, Peter M.
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2014, 4 (05) : 179 - 185
12345